Jan 04, 2017 13:05 pm UTC| Business
Caelum Program Evaluating CAEL-101 (11-1F4) for AL Amyloidosis In-licensed from Columbia University Data from ongoing Phase 1a/1b study of CAEL-101 presented by Dr. Suzanne Lentzsch at ASH have demonstrated CAEL-101 is...
Jan 04, 2017 13:05 pm UTC| Business
SEATTLE, Jan. 04, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the appointment of Marc L. Lesnick, Ph.D., as Senior Vice President, Regulatory Affairs...
Jan 04, 2017 13:05 pm UTC| Business
SEATTLE, Jan. 04, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the appointment of Marc L. Lesnick, Ph.D., as Senior Vice President, Regulatory Affairs...
Jan 04, 2017 13:05 pm UTC| Business
SEATTLE, Jan. 04, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the appointment of Marc L. Lesnick, Ph.D., as Senior Vice President, Regulatory Affairs...
Jan 04, 2017 13:05 pm UTC| Business
SEATTLE, Jan. 04, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the appointment of Marc L. Lesnick, Ph.D., as Senior Vice President, Regulatory Affairs...
Jan 04, 2017 13:05 pm UTC| Business
SEATTLE, Jan. 04, 2017 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced the appointment of Marc L. Lesnick, Ph.D., as Senior Vice President, Regulatory Affairs...
Semtech LoRa Technology Enables Nationwide LPWAN in Canada
Jan 04, 2017 13:05 pm UTC| Business
eleven-x uses LoRa Wireless RF Technology to launch first carrier-grade low power, wide area network (LPWAN) in Canada ...